One of the greatest challenges facing patent regimes in the last decade has been the boundary between human invention and nature, epitomised by advances in biotechnology. One example of this has been the ongoing litigation over a "transgenic non-human mammal" known as the "oncomouse", a genetically engineered mouse. This is an area that brings together consideration of ethics, law and science.